American Journal of Cardiology
Volume 105, Issue 3 , Pages 368-372 , 1 February 2010

Relation of Recurrence of Atrial Fibrillation After Successful Cardioversion to Renal Function

  • Martin Schmidt, MD

      Affiliations

    • Department of Cardiology, Klinikum Coburg, Coburg, Germany
    • Corresponding Author InformationCorresponding author: Tel: 49-9561-223-3223; fax: 49-9561-226-490
    • ,
  • Johannes Rieber, MD

      Affiliations

    • Department of Cardiology, Klinikum Innenstadt, Ludwig Maximilians University, Munich, Germany
    • ,
  • Marcos Daccarett, MD, MSc

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah
    • ,
  • Harald Marschang, MD

      Affiliations

    • Department of Cardiology, Klinikum Coburg, Coburg, Germany
    • ,
  • Anil-Martin Sinha, MD

      Affiliations

    • Department of Cardiology, Klinikum Coburg, Coburg, Germany
    • ,
  • Patrick Biggar, MD

      Affiliations

    • Department of Nephrology, Klinikum Coburg, Coburg, Germany
    • ,
  • Philip Jung, MD

      Affiliations

    • Department of Cardiology, Klinikum Innenstadt, Ludwig Maximilians University, Munich, Germany
    • ,
  • Markus Ketteler, MD

      Affiliations

    • Department of Nephrology, Klinikum Coburg, Coburg, Germany
    • ,
  • Johannes Brachmann, MD

      Affiliations

    • Department of Cardiology, Klinikum Coburg, Coburg, Germany
    • ,
  • Harald Rittger, MD

      Affiliations

    • Department of Cardiology, Klinikum Coburg, Coburg, Germany

Received 6 July 2009 ,Revised 8 September 2009 ,Accepted 8 September 2009.

References 

  1. Iguchi Y, Kimura K, Kobayashi K, Aoki J, Terasawa Y, Sakai K, et al. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol. 2008;102:1056–1059
  2. Vazquez E, Sanchez-Perales C, Borrego F, Garcia-Cortes MJ, Lozano C, Guzman M, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J. 2000;140:886–890
  3. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol. 2003;4:1–10
  4. Zebe H. Atrial fibrillation in dialysis patients. Nephrol Dial Transplant. 2000;15:765–768
  5. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J, et al. Risks associated with renal dysfunction in the coronary care unit. J Am Coll Cardiol. 2000;36:679–684
  6. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: full text: a report of the American College/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;8:651–745
  7. Stabile G, Berteglia E, Turco P, Zoppo F, Iuliano A, Zerbo F, et al. Role of pulmonary veins isolation in persistent atrial fibrillation ablation: the pulmonary vein isolation in persistent atrial fibrillation (PIPA) study. Pacing Clin Electrophysiol. 2009;32(suppl 1):116–119
  8. Chun K-RJ, Schmidt B, Metzner A, Tilz R, Zerm T, Köster I, et al. The “single big cryoballoon” technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J. 2009;30:699–709
  9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  10. Kang YS, Han KA, Han SY, Kim HK, Cha DR. Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population. Clin Nephrol. 2005;63:258–266
  11. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  12. Guyton AC. The surprising kidney-fluid mechanism for pressure control-its infinite gain!. Hypertension. 1990;16:725–730
  13. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: “Guyton revisited” (Review). Eur Heart J. 2005;26:11–17
  14. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int. 2002;62:1402–1407
  15. Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912–1918
  16. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45:1832–1839
  17. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation. Eur Heart J. 2006;27:512–518
  18. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol. 2008;51:1–11
  19. Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, et al. Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med. 2009;360:1606–1617
  20. Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua T. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008;26:403–411
  21. Bader M, Peters J, Baltatu O, Müller DN, Luft FC, Ganten D. Tissue-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med. 2001;79:76–102
  22. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation (A systematic review of the published data). J Am Coll Cardiol. 2007;50:2021–2028
  23. Boos CJ, Anderson RA, Lip YH. Is atrial fibrillation an inflammatory disorder?. Eur Heart J. 2006;27:136–149
  24. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115:135–143
  25. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004;65:1031–1040

PII: S0002-9149(09)02408-4

doi: 10.1016/j.amjcard.2009.09.037

American Journal of Cardiology
Volume 105, Issue 3 , Pages 368-372 , 1 February 2010

Article Tools

* Image Usage & Resolution